Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The future of antiviral drugs].

La Revue du praticien - 15 Mar 1997

Moutouh L, Calvez V, Huraux J M

Abstract excerpt

Despite much recent progress, antiviral chemotherapy has still to meet some major challenges: residual cytotoxicity of much antiviral drugs; emergence of viral strains resisting to the most specific antiviral drugs; inability of the most active antiviral drugs to suppress latent viral infections. Several approaches using gene therapy (e.g. hybridons, ribozymes, or dominant negative mutants) might theoretically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Microbial
Share to Forecasting

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Virus Latency

Share to Viruses

Source

Identifiers

PMID: 9183940

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The future of antiviral drugs].PMID 9183940Read ↗

The future of antiviralsSemantic proximity Read ↗

New perspective of small-molecule antiviral drugs development for RNA virusesSemantic proximity Read ↗

The implications of drug resistance for strategies of combination antiviral chemotherapy.Semantic proximity Read ↗

Broad-Spectrum Antiviral Strategies and Nucleoside AnaloguesSemantic proximity Read ↗

No compelling reason to adopt new antivirals whenever it is reasonable to wait.Semantic proximity Read ↗

Development of modified nucleosides that have supremely high anti-HIV activity and low toxicity and prevent the emergence of resistant HIV mutants.Semantic proximity Read ↗

[Development of drug-resistant human cytomegalovirus].Semantic proximity Read ↗

[Mechanisms of the formation of viral resistance to chemotherapeutic preparations].Semantic proximity Read ↗

[Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].Semantic proximity Read ↗

[Viral resistance to chemical preparations in experimental and clinical practice].Semantic proximity Read ↗

Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptasesSemantic proximity Read ↗

[New approaches to the treatment of the flavivirus infections].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.